A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

Publisher: Karger

E-ISSN: 1423-0399|85|1|80-87

ISSN: 0042-1138

Source: Urologia Internationalis, Vol.85, Iss.1, 2010-06, pp. : 80-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content